Immune-mediated inflammatory diseases: progress in molecular pathogenesis and therapeutic strategies
- PMID: 23557265
- DOI: 10.1586/eci.13.10
Immune-mediated inflammatory diseases: progress in molecular pathogenesis and therapeutic strategies
Abstract
The European Workshop on Immune-Mediated Inflammatory Diseases aims to exchange scientific knowledge and promote the collaboration between various disciplines (rheumatology, dermatology and gastroenterology) among physicians and scientists. This year ophthalmologists and neurologists were also present for the first time. The meeting revolved around the following topics: fibrosis, gene therapy in ophthalmology, functional genomics, challenges in human immunology, environmental factors, diabetes and metabolism, novelties in multiple sclerosis and innate lymphoid cells. The workshop was preceded by a masterclass that covered the last 15 years of IL-17/Th17 research and provided an overview on future therapeutics to battle immune-mediated inflammatory diseases.
Similar articles
-
Th17 and regulatory T cell subsets in diseases and clinical application.Int Immunopharmacol. 2011 May;11(5):533-5. doi: 10.1016/j.intimp.2011.02.020. Epub 2011 Feb 24. Int Immunopharmacol. 2011. PMID: 21354351
-
Gene therapy in immune-mediated diseases of the eye.Prog Retin Eye Res. 2003 May;22(3):277-93. doi: 10.1016/s1350-9462(02)00046-0. Prog Retin Eye Res. 2003. PMID: 12852487 Review.
-
Review of the 1st annual world congress of immunodiseases and therapeutics.Expert Rev Clin Immunol. 2010 Sep;6(5):757-9. doi: 10.1586/eci.10.54. Expert Rev Clin Immunol. 2010. PMID: 20828283
-
Cytokine-modifying therapies in immune disorders.JAAPA. 2002 Feb;15(2):25-8, 31-4. JAAPA. 2002. PMID: 11917757 No abstract available.
-
Helminths as governors of immune-mediated inflammation.Int J Parasitol. 2007 Apr;37(5):457-64. doi: 10.1016/j.ijpara.2006.12.009. Epub 2006 Dec 28. Int J Parasitol. 2007. PMID: 17313951 Review.
Cited by
-
Immune-mediated inflammatory diseases and leukocyte telomere length: A Mendelian randomization study.Front Genet. 2023 Apr 17;14:1129247. doi: 10.3389/fgene.2023.1129247. eCollection 2023. Front Genet. 2023. PMID: 37139230 Free PMC article.
-
A comparative study of the gut microbiota in immune-mediated inflammatory diseases-does a common dysbiosis exist?Microbiome. 2018 Dec 13;6(1):221. doi: 10.1186/s40168-018-0603-4. Microbiome. 2018. PMID: 30545401 Free PMC article.
-
Intestinal Permeability In Subjects With Rheumatoid Arthritis: A Critical Therapeutic Priority.Integr Med (Encinitas). 2024 Nov;23(5):16-26. Integr Med (Encinitas). 2024. PMID: 39534664 Review.
-
Pharmaceutically Active Microbial AhR Agonists as Innovative Biodrugs in Inflammation.Pharmaceuticals (Basel). 2022 Mar 10;15(3):336. doi: 10.3390/ph15030336. Pharmaceuticals (Basel). 2022. PMID: 35337134 Free PMC article. Review.
-
Unveiling the anti-inflammatory potential of Acalypha indica L. and analyzing its research trend: digging deep to learn deep.Naunyn Schmiedebergs Arch Pharmacol. 2024 Apr;397(4):1935-1956. doi: 10.1007/s00210-023-02734-9. Epub 2023 Oct 5. Naunyn Schmiedebergs Arch Pharmacol. 2024. PMID: 37796311 Review.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical